MicrobiologyPLOS ONEPeer-reviewed
A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV-2 main protease.
J. D. Baker, R. L. Uhrich, G. C. Kraemer…·B. C. Kraemer
This paper identifies hepatitis C antivirals as inhibitors of SARS-CoV-2 main protease through a drug repurposing screen of ~6,070 drugs.
DOI 10.1371/journal.pone.0245962